HCPCS Code Descriptor:
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
Route of Administration:
Fosaprepitant is an Oncology-Anti-Emetic drug manufactured by Actavis and administered via the Intravenous route of administration. The J Code: J1456 is aligned to the drug Fosaprepitant.